935854-32-3Relevant academic research and scientific papers
3- (SULPHONYLAMINO) -PHENYL-2 -HYDROXY-ETHYLAMINO DERIVATIVES USEFUL AS BETA-AGONISTS, PROCESSES FOR PREPARING THEM AND THEIR USE AS MEDICAMENTS
-
Page/Page column 37, (2008/12/08)
The present invention relates to compounds of general formula (I), wherein the groups A, L, R1 and R2 have the meanings given in the claims and specification, the tautomers, racemates, enantiomers, diastereomers, mixtures thereof, so
Novel Beta-Agonists, Process for Their Preparation and Their Use as Medicaments
-
Page/Page column 13-14, (2009/01/20)
Compounds of general formula (I) which are selective beta-3-agonists and useful for the treatment of obesity and type II diabetes. Exemplary compounds are: [4-(1-{3-[2-(3-phenylsulphonylamino-phenyl)-2-hydroxy-ethylamino]-3-methyl-butyl}-1H-imidazol-4-yl)
Indol-containing beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
-
Page/Page column 10, (2010/11/27)
The present invention relates to new beta-agonists of general formula (I) wherein the groups R1 and R2 have the meanings given in the claims and specification, the tautomers, racemates, enantiomers, diastereomers, solvates, hydrates,
Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
-
Page/Page column 13, (2010/11/27)
The present invention relates to new beta-agonists of general formula (I) wherein the groups R1 to R4 have the meanings given in ths claims and specification, the tautomers, racemates, enantiomers, diastereomers, solvates, hydrates,
